152 related articles for article (PubMed ID: 12193530)
21. The N-terminal membrane anchor domain of the membrane-bound prostacyclin synthase involved in the substrate presentation of the coupling reaction with cyclooxygenase.
Ruan KH; Deng H; Wu J; So SP
Arch Biochem Biophys; 2005 Mar; 435(2):372-81. PubMed ID: 15708381
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching.
Huang JC; Wun WS; Goldsby JS; Matijevic-Aleksic N; Wu KK
Hum Reprod; 2004 Dec; 19(12):2900-6. PubMed ID: 15489241
[TBL] [Abstract][Full Text] [Related]
23. Transcriptional cofactors exhibit differential preference toward peroxisome proliferator-activated receptors alpha and delta in uterine cells.
Lim HJ; Moon I; Han K
Endocrinology; 2004 Jun; 145(6):2886-95. PubMed ID: 15001550
[TBL] [Abstract][Full Text] [Related]
24. Peroxisome proliferator-activated receptor delta activation promotes cell survival following hypertonic stress.
Hao CM; Redha R; Morrow J; Breyer MD
J Biol Chem; 2002 Jun; 277(24):21341-5. PubMed ID: 11927585
[TBL] [Abstract][Full Text] [Related]
25. Prostacyclin signaling in the kidney: implications for health and disease.
Nasrallah R; Hébert RL
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F235-46. PubMed ID: 16006589
[TBL] [Abstract][Full Text] [Related]
26. Fatty acids and immune responses--a new perspective in searching for clues to mechanism.
Hwang D
Annu Rev Nutr; 2000; 20():431-56. PubMed ID: 10940341
[TBL] [Abstract][Full Text] [Related]
27. [A new mechanism of COX-2 in inflammation].
Sano H
Ryumachi; 2002 Jun; 42(3):560-72. PubMed ID: 12166110
[No Abstract] [Full Text] [Related]
28. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
Kliewer SA; Lehmann JM; Milburn MV; Willson TM
Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
[TBL] [Abstract][Full Text] [Related]
29. Antitumour actions of highly unsaturated fatty acids: cell signalling and apoptosis.
Leaver HA; Rizzo MT; Whittle IR
Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):1-3. PubMed ID: 12051951
[No Abstract] [Full Text] [Related]
30. Increased bone mass in adult prostacyclin-deficient mice.
Nakalekha C; Yokoyama C; Miura H; Alles N; Aoki K; Ohya K; Morita I
J Endocrinol; 2010 Feb; 204(2):125-33. PubMed ID: 19906840
[TBL] [Abstract][Full Text] [Related]
31. Inflammation. Signalling the fat controller.
Serhan CN
Nature; 1996 Nov; 384(6604):23-4. PubMed ID: 8900268
[No Abstract] [Full Text] [Related]
32. Activation of peroxisome proliferator-activated receptor gamma suppresses inducible cyclooxygenase and nitric oxide synthase during oral mucosal ulcer healing.
Slomiany BL; Slomiany A
J Physiol Pharmacol; 2002 Jun; 53(2):159-69. PubMed ID: 12120893
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin biology.
Crofford LJ
Gastroenterol Clin North Am; 2001 Dec; 30(4):863-76. PubMed ID: 11764532
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of cyclooxygenase 2 derived endogenous prostacyclin in mouse preimplantation embryo development in vitro.
Pakrasi PL; Jain AK
Life Sci; 2007 Mar; 80(16):1503-7. PubMed ID: 17328923
[TBL] [Abstract][Full Text] [Related]
35. PPARgamma ligands as modulators of inflammatory and catabolic responses in arthritis. An overview.
Fahmi H; Pelletier JP; Martel-Pelletier J
J Rheumatol; 2002 Jan; 29(1):3-14. PubMed ID: 11824967
[No Abstract] [Full Text] [Related]
36. Novel mechanism of the vascular protector prostacyclin: regulating microRNA expression.
Mohite A; Chillar A; So SP; Cervantes V; Ruan KH
Biochemistry; 2011 Mar; 50(10):1691-9. PubMed ID: 21250659
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandins and the regulation of tumor growth.
Bishop-Bailey D; Calatayud S; Warner TD; Hla T; Mitchell JA
J Environ Pathol Toxicol Oncol; 2002; 21(2):93-101. PubMed ID: 12086407
[TBL] [Abstract][Full Text] [Related]
38. The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.
Shi Y; Hon M; Evans RM
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2613-8. PubMed ID: 11867749
[TBL] [Abstract][Full Text] [Related]
39. Comparative analysis of the in vivo angiogenic properties of stable prostacyclin analogs: a possible role for peroxisome proliferator-activated receptors.
Pola R; Gaetani E; Flex A; Aprahamian TR; Bosch-Marcé M; Losordo DW; Smith RC; Pola P
J Mol Cell Cardiol; 2004 Mar; 36(3):363-70. PubMed ID: 15010275
[TBL] [Abstract][Full Text] [Related]
40. Elucidation of mechanisms of the reciprocal cross talk between gonadotropin-releasing hormone and prostaglandin receptors.
Naidich M; Shterntal B; Furman R; Pawson AJ; Jabbour HN; Morgan K; Millar RP; Jia J; Tomic M; Stojilkovic S; Stern N; Naor Z
Endocrinology; 2010 Jun; 151(6):2700-12. PubMed ID: 20392830
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
